Botox Approved by FDA for Bladder Control
The US Food and Drug Administration (FDA) has approved Botox made by Allergan to treat a specific type of overactive bladder. Thus, this popular treatment for wrinkles is all set to be used more widely to treat patients having bladder issues. The FDA has allowed the injection of Botox into the bladders of those of who suffer from loss of bladder control due to nervous system damage, spinal cord injury or multiple sclerosis. Last month, Botox was approved for similar use in Europe.
Botox for Bladder
Allergan said it will try get approval for Botox to treat a broader population of patients suffering from overactive bladder. The company expects the FDA approval to fetch sales of around $40 million by 2017. Overactive bladder can cause frequent urination and uncontrollable urge to urinate. A single Botox injection into the bladder can raise its storage capacity, while relaxing the organ. The effect can last for nine months.
Botox’s Various Uses
Around 60% to 80% of patients suffering from spinal cord injury or multiple sclerosis experience bladder problems. Botox gets 50% of its annual revenue of $1.5 billion from cosmetic treatment to reduce wrinkles. It has also been approved to prevent migraines, and treat neck pain, upper limb spasticity, and eye muscle problems such as eyelid spasms.
Alternative to Standard Pills
The FDA approval means Botox can be used by patients whose bladder control problems cannot be treated by standard pills known as anticholinergics, which include Astellas and oxybutynin, and Vesicare made by GlaxoSmithKline.